Nevro expects new results from two randomized trials will help it bring its HF10 spinal cord stimulation (SCS) therapy to hundreds of thousands of patients whose pain is not adequately treated with medical therapy.
Nevro markets the Senza systems that deliver its HF10 therapy, a proprietary 10 kHz waveform developed to treat chronic pain....